<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27973411</article-id><article-id pub-id-type="pmc">5188457</article-id><article-id pub-id-type="doi">10.3390/nu8120802</article-id><article-id pub-id-type="publisher-id">nutrients-08-00802</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Effects of Low versus High Glycemic Index Sugar-Sweetened Beverages on Postprandial Vasodilatation and Inactivity-Induced Impairment of Glucose Metabolism in Healthy Men</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Keller</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="af1-nutrients-08-00802">1</xref></contrib><contrib contrib-type="author"><name><surname>Kahlh&#x000f6;fer</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="af1-nutrients-08-00802">1</xref></contrib><contrib contrib-type="author"><name><surname>Peter</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="af2-nutrients-08-00802">2</xref><xref ref-type="aff" rid="af3-nutrients-08-00802">3</xref><xref ref-type="aff" rid="af4-nutrients-08-00802">4</xref></contrib><contrib contrib-type="author"><name><surname>Bosy-Westphal</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="af1-nutrients-08-00802">1</xref><xref rid="c1-nutrients-08-00802" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-08-00802"><label>1</label>Institute of Nutritional Medicine, University of Hohenheim, 70599 Stuttgart, Germany; <email>judith.karschin@uni-hohenheim.de</email> (J.K.); <email>julia@kahlhoefers.de</email> (J.K.)</aff><aff id="af2-nutrients-08-00802"><label>2</label>Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University Hospital of T&#x000fc;bingen, 72076 T&#x000fc;bingen, Germany; <email>Andreas.Peter@med.uni-tuebingen.de</email></aff><aff id="af3-nutrients-08-00802"><label>3</label>Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich, University of T&#x000fc;bingen, 72076 T&#x000fc;bingen, Germany</aff><aff id="af4-nutrients-08-00802"><label>4</label>German Center for Diabetes Research (DZD), 72076 T&#x000fc;bingen, Germany</aff><author-notes><corresp id="c1-nutrients-08-00802"><label>*</label>Correspondence: <email>Anja.Bosy-Westphal@uni-hohenheim.de</email>; Tel.: +49-711-459-24690; Fax: +49-711-459-24699</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><volume>8</volume><issue>12</issue><elocation-id>802</elocation-id><history><date date-type="received"><day>07</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>05</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2016</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Intake of sugar-sweetened beverages (SSB) may contribute to cardiovascular risk. The aim of this study was to investigate whether functional sugars with low compared to high glycemic index (GI) have beneficial effects on arterial stiffness during a period of low-physical activity. In a controlled cross-over dietary intervention (55% CHO, 30% fat, 15% protein), 13 healthy men (age: 23.7 &#x000b1; 2.2 years, body mass index: 23.6 &#x000b1; 1.9 kg/m<sup>2</sup>) completed 2 &#x000d7; 1 week of low physical activity following 1 week of normal physical activity (2363 &#x000b1; 900 vs. 11,375 &#x000b1; 3124 steps/day). During inactive phases participants consumed either low-GI (isomaltulose) or high-GI SSB (maltodextrin-sucrose), providing 20% of energy requirements. Postprandial vasodilatation (augmentation index, AIx), insulin sensitivity (IS) and Glucagon-like-peptide 1 (GLP-1) responses were measured during a meal test before and after SSB-intervention. Compared to maltodextrin-sucrose-SSB, postprandial vasodilatation was prolonged (AIx after 120 min: 9.9% &#x000b1; 4.3% vs. 11.4% &#x000b1; 3.7%, <italic>p</italic> &#x0003c; 0.05) and GLP-1 secretion was higher with isomaltulose-SSB (total area under the GLP-1 curve (tAUC<sub>GLP</sub>)-1: 8.0 &#x000b1; 4.4 vs. 5.4 &#x000b1; 3.4 pM &#x000d7; 3 h; <italic>p</italic> &#x0003c; 0.05). One week of low-physical activity led to impaired IS that was attenuated with low-GI SSB consumption, but did not affect arterial stiffness (<italic>p</italic> &#x0003e; 0.05). Higher postprandial GLP-1 secretion after intake of low compared to high-GI beverages may contribute to improved postprandial vasodilatation. Although one week of low-physical activity led to marked impairment in IS, it had no effect on arterial stiffness in healthy men.</p></abstract><kwd-group><kwd>arterial stiffness</kwd><kwd>vasodilatation</kwd><kwd>GLP-1</kwd><kwd>glycemic index</kwd><kwd>sugar-sweetened beverages</kwd><kwd>low-physical activity</kwd><kwd>healthy men</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-08-00802"><title>1. Introduction</title><p>Despite recommendations to limit consumption of sugar sweetened beverages (SSB), intake has been increasing in the last decades [<xref rid="B1-nutrients-08-00802" ref-type="bibr">1</xref>]. Germany has the highest sale numbers of SSBs, compared to other European countries [<xref rid="B2-nutrients-08-00802" ref-type="bibr">2</xref>]. The corresponding high glycemic and insulinemic responses associated with SSB consumption not only promote weight gain and contribute to increased risk of type 2 diabetes [<xref rid="B3-nutrients-08-00802" ref-type="bibr">3</xref>] but may also increase blood pressure (BP) and serum lipids independent of body weight [<xref rid="B4-nutrients-08-00802" ref-type="bibr">4</xref>]. Cross-sectional studies indicate direct associations between SSB consumption and BP as well as cardiovascular risk factors, such as low density lipoprotein (LDL) cholesterol and triglycerides [<xref rid="B5-nutrients-08-00802" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-08-00802" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-08-00802" ref-type="bibr">7</xref>]. Weight-loss induced improvement in BP is also better with a low glycemic load diet compared to a low fat diet (43% CHO and glycemic index, GI = 50 vs. 65% CHO and GI = 82) [<xref rid="B8-nutrients-08-00802" ref-type="bibr">8</xref>] and decrease in pulse wave velocity and 24-h BP was found with a 6-month low-GI diet intervention but not with a high-GI diet [<xref rid="B9-nutrients-08-00802" ref-type="bibr">9</xref>].</p><p>Although it is suggested that greater SSB consumption may contribute to the development of hypertension, adverse lipid parameters and coronary heart disease, intervention studies investigating the effect of SSB consumption on arterial stiffness are lacking [<xref rid="B10-nutrients-08-00802" ref-type="bibr">10</xref>].</p><p>Because hyperglycemia can lead to insulin resistance and thus to endothelial dysfunction [<xref rid="B11-nutrients-08-00802" ref-type="bibr">11</xref>] a diet with a high glycemic load may be causally related to hypertension. In insulin sensitive subjects, insulin-signaling pathways lead to an activation of endothelial nitric oxide (NO) synthase via phosphatidylinositol 3-kinase and Akt and thus increase the bioavailability of the vasodilating NO in endothelial cells [<xref rid="B12-nutrients-08-00802" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-08-00802" ref-type="bibr">13</xref>]. In line with this hypothesis, insulin-mediated vasodilatation is impaired with insulin resistance [<xref rid="B11-nutrients-08-00802" ref-type="bibr">11</xref>] and increased BP [<xref rid="B14-nutrients-08-00802" ref-type="bibr">14</xref>]. </p><p>Compared to conventional sugar, SSBs sweetened with functional low-GI sugar types had beneficial effects on low-physical activity-induced impairment of glucose metabolism [<xref rid="B15-nutrients-08-00802" ref-type="bibr">15</xref>] and may therefore reduce BP. Isomaltulose (Palatinose&#x02122;) and sucrose are both disaccharides consisting of glucose and fructose, providing the same number of calories but differing in their glycosidic bond. In isomaltulose the molecules are linked &#x003b1;-1,6 instead of &#x003b1;-1,2 (in sucrose) which results in slower absorbability [<xref rid="B16-nutrients-08-00802" ref-type="bibr">16</xref>] and thus a lower GI in isomaltulose than in sucrose (GI: 32 for isomaltulose vs. 64 for sucrose) [<xref rid="B17-nutrients-08-00802" ref-type="bibr">17</xref>]. </p><p>Compared to beverages sweetened with maltodextrin-sucrose (e.g., commonly used in sport drinks [<xref rid="B18-nutrients-08-00802" ref-type="bibr">18</xref>], beverages sweetened with functional low-GI sugar isomaltulose had beneficial effects on inactivity-induced impairment of glucose metabolism [<xref rid="B15-nutrients-08-00802" ref-type="bibr">15</xref>] and thus insulin-mediated vasodilatation. By contrast, acute effects of postprandial relaxation of the vascular wall may be lower with isomaltulose compared to sucrose because of lower postprandial insulin secretion. However, the intake of low-GI isomaltulose not only resulted in lower insulin levels but also in a higher Glucagon-like-peptide 1 (GLP-1) response [<xref rid="B19-nutrients-08-00802" ref-type="bibr">19</xref>] and recent studies have shown that the incretin hormone GLP-1 has beneficial effects on endothelium-dependent vasodilatation in humans [<xref rid="B20-nutrients-08-00802" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-08-00802" ref-type="bibr">21</xref>]. Despite lower insulin secretion after low-GI isomaltulose SSB intake, postprandial vasodilatation may therefore be similar or even higher compared to high-GI SSB due to a higher postprandial GLP-1 response.</p><p>The present study investigates the effect of acute and chronic (one week) intake of high- vs. low-GI SSB on arterial stiffness in young healthy subjects. In contrast to the proposed effects of SSB consumption, physical inactivity is known to impair insulin sensitivity [<xref rid="B22-nutrients-08-00802" ref-type="bibr">22</xref>] and endothelial function [<xref rid="B23-nutrients-08-00802" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-08-00802" ref-type="bibr">24</xref>] and thus represents a metabolic condition vulnerable for the adverse effects of SSB consumption. Impaired insulin sensitivity has been shown to be an early response to inactivity with a reduction of insulin action already occurring within one day of prolonged sitting [<xref rid="B25-nutrients-08-00802" ref-type="bibr">25</xref>]. We therefore hypothesized that one-week consumption of low-GI compared to high-GI SSBs at a low level of physical activity leads to a better maintenance of insulin sensitivity and thus to lower impairment of low physical activity-induced endothelial function.</p></sec><sec id="sec2-nutrients-08-00802"><title>2. Materials and Methods</title><p>Sixteen healthy young men were recruited at the campus of the University of Stuttgart and Hohenheim between August 2014 and February 2015. All subjects completed a medical history and a physical examination to assess health status. Inclusion criteria were: high level of physical activity (active lifestyle with &#x0003e;10,000 steps/day and exercise workload &#x02265; 5 times per week) and male sex. Participants did not use any medication on a daily basis. Exclusion criteria for enrolment included chronic disease, smoking, food allergies or special diets (e.g., vegetarian). Three subjects were excluded from analysis due to lack of compliance with the study protocol. The study protocol was approved by the ethics committee of the Medical council of Baden-W&#x000fc;rttemberg, Germany, in August 2014 (ethic approval code: F-2014-072; trial registration in ClinicalTrials.gov: NCT02321033). All participants provided informed written consent before participation according to the Declaration of Helsinki. Based on the data of Krogh-Madsen et al., at 80% power and an alpha level of 5%, 10 participants per group were needed to detect a 12% difference in insulin sensitivity. In order to account for possible drop-out, we included 16 volunteers [<xref rid="B22-nutrients-08-00802" ref-type="bibr">22</xref>]. Precision of pulse wave velocity (PWV) and aortal BP (aBP) was determined in a group of five individuals (coefficient of variation (CV): CV<sub>PWV</sub>: 3.2%; CV<sub>aBP</sub>: 6.8%). It was calculated that a difference of 6% in PWV and aBP could be detected with a power of 80% and 5% significance level in 13 subjects.</p><sec id="sec2dot1-nutrients-08-00802"><title>2.1. Study Protocol</title><p>An outline of the study protocol is shown in the flow diagram in <xref ref-type="fig" rid="nutrients-08-00802-f001">Figure 1</xref>. The 2 &#x000d7; 2 week controlled cross-over dietary intervention was carried out at the Institute of Nutritional Medicine at the University of Hohenheim. </p><p>Over a period of two weeks, all subjects underwent one week of habitual physical activity (=active baseline) followed by one week of low-physical activity (&#x0003c;3000 steps/day) with either low-GI (LGI, isomaltulose) or high-GI (HGI, maltodextrin-sucrose) sugar-sweetened beverage intake, providing 20% of energy requirements. Energy requirement during the inactive period was estimated by multiplying resting energy expenditure (measured by indirect calorimetry, Quark QMR, Cosmed GmbH, Rome, Italy) by a physical activity level of 1.4, that resembles sedentary behavior. Physical activity was monitored throughout the study using the ActivPAL device (PAL Technologies Ltd., Glasgow, UK). Wash out period between low-GI and high-GI intervention was at least three weeks.</p></sec><sec id="sec2dot2-nutrients-08-00802"><title>2.2. Diet Intervention</title><p>The controlled diet (55% CHO, 30% fat and 15% protein) started at the fourth day in the active baseline period and was maintained for 11 days (until the end of the inactive intervention period). Returned leftovers were weighted to calculate exact dietary intake. During the inactive phase, 55% CHO intake was stratified to 35% from solid food and 20% was provided as sugar-sweetened beverages with either low-GI isomaltulose (Palatinose&#x02122;, provided by Beneo GmbH, Mannheim, Germany; GI = 32) or high-GI maltodextrin-sucrose (mixture of 75% maltodextrin (Nutricia GmbH, Erlangen, Germany) and 25% sucrose, adapted for sweetness; GI = 90). A detailed description of the diet is given elsewhere [<xref rid="B15-nutrients-08-00802" ref-type="bibr">15</xref>] and dietary intake, stratified by activity, low-GI and high-GI intervention is shown in <xref ref-type="app" rid="app1-nutrients-08-00802">Supplemental Table S1</xref>. Total amount of isomaltulose or maltodextrin-sucrose intake was 139 &#x000b1; 13 g/day, respectively. Participants were instructed to consume SSBs in between meals three times per day. The beverages were provided in a single-blind randomized order.</p></sec><sec id="sec2dot3-nutrients-08-00802"><title>2.3. Physical Activity</title><p>Physical activity was continuously monitored using the triaxial activity monitor ActivPAL<sup>TM</sup> (PAL Technologies Ltd., Glasgow, UK). The device was fixed on the upper thigh with waterproof patches and was worn during the active baseline and inactive intervention periods. Step counts per day were used to define physical activity. During the active baseline periods steps should exceed &#x0003e;10,000 steps/day, which is recommended for healthy lifestyle in adults [<xref rid="B26-nutrients-08-00802" ref-type="bibr">26</xref>]. During low physical activity, steps were limited to &#x0003c;3000 steps/day to induce a vulnerable metabolic situation in healthy men. Sedentary behavior is defined as any waking behavior characterized by energy expenditure &#x02264; 1.5 metabolic equivalents (METs) like viewing television, video game playing, computer use, driving automobiles, and reading. By contrast, inactive behavior describes insufficient amounts of moderate- to vigorous-intensity physical activity (i.e., not meeting specified physical activity guidelines) [<xref rid="B27-nutrients-08-00802" ref-type="bibr">27</xref>]. The distinction between the two is important because a person can be sedentary throughout the entire day but at the same time physically active when engaging in exercise for 1 h in the evening. In the present study the participants were instructed to abstain from any activity &#x0003e;1.5 MET and spend their day sitting at desks or watching TV and they were also not allowed to do any exercise. According to the definitions the participants were therefore both, sedentary and inactive. Throughout the paper we use the term &#x0201c;low physical activity&#x0201d; for simplification.</p></sec><sec id="sec2dot4-nutrients-08-00802"><title>2.4. Body Composition</title><p>Height was measured to the nearest 0.1 cm by stadiometer (seca 285, seca GmbH &#x00026; Co. KG, Hamburg, Germany). Body weight and fat mass were measured on a calibrated impedance scale (seca mBCA 515, seca GmbH &#x00026; Co. KG, Hamburg, Germany). Measurements were performed before breakfast, in underwear, without shoes and after voiding.</p></sec><sec id="sec2dot5-nutrients-08-00802"><title>2.5. Blood Pressure, Pulse Wave Analysis and Pulse Wave Velocity (PWV)</title><p>Brachial BP and pulse wave analysis were conducted in a supine position using the Vicorder device (SMT medical, W&#x000fc;rzburg, Germany). BP was measured after at least 5 min rest on the right upper arm in a quiet room. The average of the last two of three measurements was used for further analysis.</p><p>Heart rate (HR), central BP (cBP) and augmentation index (AIx) were analyzed according to manufactures guidelines for pulse wave analysis (Vicorder, SMT medical, 2009). After a normal BP measurement the cuff was inflated to diastolic BP and waveforms were recorded over at least 10 consecutive heartbeats, free from arrhythmia, to pick up the pulse wave. Heart rate was measured and AIx and cBP were estimated with the inbuilt and evaluated algorithm [<xref rid="B28-nutrients-08-00802" ref-type="bibr">28</xref>].</p><p>Repeatability of pulse wave velocity (PWV) measurement using the Vicorder device, was previously tested in an elderly population with high repeatability by McGreevy et al. [<xref rid="B29-nutrients-08-00802" ref-type="bibr">29</xref>]. Simultaneous measured waveforms were recorded by a volume displacement technique, using blood pressure cuffs placed around the upper thigh and neck (over the arteria carotis), on the right body site. Standard path length (L) indicated by the Vicorder instruction guidelines is the distance from the suprasternal notch to the middle of the thigh cuff. The cuffs were inflated to 60 mmHg, and high quality waveforms were recorded for 10 heartbeats with the patient lying in supine position with a 30&#x000b0; elevated head and shoulder. The measurement was stopped manually by the operator. The Vicorder software automatically calculates transit time (&#x02206;t) between carotid and femoral pulse waves. PWV was calculated as path length divided by the transit time of the pulse wave (PWV = L/&#x02206;t (m/s)) [<xref rid="B30-nutrients-08-00802" ref-type="bibr">30</xref>]. Two PWV readings were taken and an average value was documented.</p><p>BP, pulse wave analysis and PWV were assessed at the active baseline and the end of the inactive intervention period. To measure acute effects of sugar-sweetened beverage intake on cardiovascular dynamics, measurements were also conducted during a meal test with low- and high-GI SSB at 0, 30, 60, 90, 120 and 180 min after SSB intake.</p></sec><sec id="sec2dot6-nutrients-08-00802"><title>2.6. Fasting and Postprandial Glucose Metabolism</title><p>Daylong interstitial glycemia and glucose variability was measured using continuous glucose monitoring system Dexcom G4 (Nintamed GmbH &#x00026; Co. KG, Mainz, Germany). The device was continuously worn during both active and inactive phases. Glycemia over 24 h was determined as total area under the curve (tAUC). Glucose variability was assessed using mean amplitude of glycemic excursion (MAGE):
<disp-formula id="FD1-nutrients-08-00802"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mstyle mathsize="70%" displaystyle="true"><mml:mo>&#x02211;</mml:mo></mml:mstyle><mml:mfrac><mml:mi>&#x003bb;</mml:mi><mml:mi>x</mml:mi></mml:mfrac><mml:mo>&#x000a0;</mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>&#x003bb;</mml:mi><mml:mo>&#x0003e;</mml:mo><mml:mi>y</mml:mi><mml:mo>&#x000a0;</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic>&#x003bb;</italic> is the difference from peak to nadir, <italic>x</italic> is the number of valid observations, and <italic>y</italic> is 1 SD of mean glucose in a 24-h period [<xref rid="B31-nutrients-08-00802" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-08-00802" ref-type="bibr">32</xref>]. Daylong insulin secretion was assessed by 24-h c-peptide excretion at the active baseline and the end of the inactive intervention phases. </p><p>Fasting blood samples were collected after an overnight fast (&#x02265;10 h) at the active baseline and the end of the inactive phase to assess fasting insulin sensitivity (IS) using homeostasis model assessment index (HOMA-IR): fasting glucose (mmol/L) &#x000d7; fasting insulin (&#x000b5;U/L)/22.5 [<xref rid="B33-nutrients-08-00802" ref-type="bibr">33</xref>]. Participants underwent a standard oral glucose tolerance test (OGTT, intake of 75 g glucose) to assess postprandial IS by Matsuda whole-body IS Index (Matsuda-ISI): 10,000/(&#x0221a; (fasting glucose &#x000d7; fasting insulin) &#x000d7; (mean glucose &#x000d7; mean insulin during OGTT) [<xref rid="B34-nutrients-08-00802" ref-type="bibr">34</xref>]. </p><p>Meal tests with low- and high-GI SSBs were performed with either 37 g isomaltulose or 28 g maltodextrin + 9 g sucrose sweetened test drink. Venous blood was sampled at 0, 30, 60, 90, 120 and 180 min after sugar consumption. Insulin, glucose and GLP-1 (only during meal test) responses were determined and calculated as incremental AUC (iAUC) or total AUC (tAUC) using the trapezoid rule [<xref rid="B35-nutrients-08-00802" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot7-nutrients-08-00802"><title>2.7. Blood Sampling and Analytical Methods</title><p>Blood sampling was conducted by vein cannula. Serum insulin was determined by photometry (Beckman Coulter, Brea, CA, USA). Glucose was measured using hexokinase method (Beckman Coulter, Brea, CA, USA). Blood samples to analyze active GLP-1 were withdrawn directly into BD P800 plasma tubes (Becton Dickinson, Heidelberg, Germany) containing an inhibitory mix (i.e., Dipeptidyl peptidase 4 inhibitor), kept in ice and centrifuged in a refrigerated centrifuge within 10 min. Aliquots were stored at &#x02212;80 &#x000b0;C. Circulating levels of active GLP-1 (7-36) were quantified at the University of T&#x000fc;bingen using the chemiluminescent high sensitivity GLP-1 Active ELISA Kit (#EZGLPHS-35K, Merck Millipore, Darmstadt, Germany). Measurements were performed in duplicate on the Glo-Max Luminometer (Promega GmbH, Mannheim, Germany) applying the five-parameter logistic (GraphPad Prism Software, La Jolla, CA, USA) according to the manufacturer&#x02019;s instructions. Urinary c-peptide was analyzed with luminescence immunoassay.</p></sec><sec id="sec2dot8-nutrients-08-00802"><title>2.8. Statistical Analysis</title><p>Data are presented as means &#x000b1; SD, unless otherwise stated. Analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA). Normal distribution was assessed by Kolmogorov-Smirnov test. The effect of activity or GI intervention or activity &#x000d7; GI was tested using two-way ANOVA followed by Bonferroni post hoc tests. <italic>p</italic>-values of significant differences between active baseline and the corresponding inactive phase were subsequently analyzed using two-tailed paired <italic>t</italic>-test. Baseline values for GLP-1 during meal test were considered as a covariate using repeated measures analysis of covariance (RM-ANCOVA). <italic>p</italic> values &#x0003c; 0.05 were considered statistically significant. </p></sec></sec><sec id="sec3-nutrients-08-00802"><title>3. Results</title><p>Baseline characteristics and changes in body weight, fat mass and lipid profile with low-physical activity and diet intervention are summarized in <xref ref-type="table" rid="nutrients-08-00802-t001">Table 1</xref>. At baseline, body mass index (BMI) ranged between 20.8 and 28.0 kg/m<sup>2</sup>, with two participants being overweight (BMI: 25.9 and 28.1 kg/m<sup>2</sup>). Physical activity was significantly reduced during both inactive phases, with no difference between low-GI and high-GI interventions (&#x00394; low-GI: &#x02212;80%, &#x00394; high-GI: &#x02212;79%, <italic>p</italic> &#x0003e; 0.05). During low physical activity with the high-GI SSB intervention a slight weight loss (&#x00394; high-GI: &#x02212;0.5 &#x000b1; 0.7 kg) was observed whereas fat mass increased with both inactive phases without a difference between low and high-GI SSB interventions. Triglycerides (TG) and cholesterin/high density lipoprotein (HDL)-ratio increased, and HDL decreased with low physical activity with no difference between GI interventions (<xref ref-type="table" rid="nutrients-08-00802-t001">Table 1</xref>).</p><sec id="sec3dot1-nutrients-08-00802"><title>3.1. Effect of Low vs. High-GI SSB Intake on Postprandial GLP-1 Secretion and Parameters of Arterial Stiffness</title><p>GLP-1 response and change in augmentation index after intake of 37 g low-GI isomaltulose vs. 37 g high-GI maltodextrin-sucrose SSB at the end of the inactive condition are shown in <xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>. Postprandial GLP-1 levels were higher 30, 60 and 90 min after low-GI compared to high-GI SSB intake (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>A). tAUC of postprandial GLP-1 response was significantly higher with low-GI compared to high-GI SSB intake (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>B). Baseline fasting GLP-1 levels tended to be higher with low-GI intervention (low-GI: 3.1 &#x000b1; 2.4 pM vs. high-GI: 2.2 &#x000b1; 1.3 pM, <italic>p</italic> = 0.31), but GLP-1 response (tAUC) remained significant after controlling for these differences (RM-ANCOVA, <italic>p</italic> &#x0003c; 0.05). Postprandial vasodilatation shown as augmentation index (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>C) was prolonged with low-GI compared to high-GI SSB (AIx after 120 min: 9.9% &#x000b1; 4.3% vs. 11.4% &#x000b1; 3.7%, <italic>p</italic> &#x0003c; 0.05), whereas tAUC of the augmentation index was not different (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>D).</p></sec><sec id="sec3dot2-nutrients-08-00802"><title>3.2. Effect of Low-GI vs. High-GI Intervention on Low Physical Activity-Induced Changes in Glucose Homeostasis</title><p>Changes in insulin sensitivity and insulin secretion due to low physical activity with low and high-GI SSB intervention are shown in <xref ref-type="table" rid="nutrients-08-00802-t002">Table 2</xref> and <xref ref-type="fig" rid="nutrients-08-00802-f003">Figure 3</xref>. Fasting insulin and HOMA-IR significantly increased and Matsuda-ISI decreased due to low physical activity with both GI interventions. These impairments in fasting and postprandial insulin sensitivity were significantly lower with the low-GI compared to the high-GI SSB intervention (<xref ref-type="table" rid="nutrients-08-00802-t002">Table 2</xref>). The 24-h c-peptide excretion (<xref ref-type="table" rid="nutrients-08-00802-t002">Table 2</xref>), daytime glycemia (iAUC between 9 h and 23 h) and glucose variability (MAGE) (<xref ref-type="fig" rid="nutrients-08-00802-f003">Figure 3</xref>), were maintained with low physical activity at the low-GI SSB intervention but increased with low physical activity at the high-GI SSB intervention (daytime glycemia: &#x00394; low-GI: 40 &#x000b1; 121; &#x00394; high-GI: 84 &#x000b1; 129 mg/dl*min; MAGE: &#x00394; low-GI:&#x02212;0.2 &#x000b1; 0.5; &#x00394; high-GI: 0.7 &#x000b1; 0.6, both &#x00394; high-GI <italic>p</italic> &#x0003c; 0.05). MAGE was significantly lower with low physical activity + low-GI compared to low physical activity + high-GI (low-GI: 1.8 &#x000b1; 0.4; high-GI: 2.7 &#x000b1; 0.5, <italic>p</italic> &#x0003c; 0.05, <xref ref-type="fig" rid="nutrients-08-00802-f003">Figure 3</xref>B). While there was no GI or activity &#x000d7; GI effect in daytime glycemia, MAGE was affected by GI and activity &#x000d7; GI (<italic>p</italic> &#x0003c; 0.05 tested with two-way ANOVA, <xref ref-type="fig" rid="nutrients-08-00802-f003">Figure 3</xref>).</p></sec><sec id="sec3dot3-nutrients-08-00802"><title>3.3. Impact of Low-GI vs. High-GI SSB Intake on Low Physical Activity-Induced Changes in BP and Parameters of Arterial Stiffness</title><p>Changes in BP and parameters of arterial stiffness due to low physical activity stratified by GI intervention are summarized in <xref ref-type="table" rid="nutrients-08-00802-t003">Table 3</xref>. All parameters (systolic BP, diastolic BP, central BP, AIx and PWV) remained unchanged with low physical activity and did not differ between both interventions.</p></sec></sec><sec id="sec4-nutrients-08-00802"><title>4. Discussion</title><p>Regarding the acute effect of SSB intake on postprandial relaxation of the vascular wall, vasodilatation was similar with low-GI isomaltulose compared to high-GI maltodextrin-sucrose intake. This equal effect occurred despite a lower insulin secretion with isomaltulose intake and might be explained by higher postprandial GLP-1 levels that may also contribute to postprandial vasodilatation. In the long term, one week of low physical activity led to impaired basal and postprandial insulin sensitivity that were attenuated with low GI compared to high GI SSB consumption, but did not affect arterial stiffness.</p><sec id="sec4dot1-nutrients-08-00802"><title>4.1. Acute Effect of Low- vs. High-GI SSB Intake on Insulin, GLP-1 and Associated Endothelial Function</title><p>The present study has shown that compared to high-GI SSB intake, low-GI SSB intake led to higher GLP-1 secretion with slightly prolonged but no difference in total postprandial vasodilation (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>). Previously, we have shown that postprandial insulin response (iAUC as well as tAUC) was significantly lower with low-GI compared to high-GI SSB consumption [<xref rid="B15-nutrients-08-00802" ref-type="bibr">15</xref>]. A 50% lower insulin secretion with isomaltulose compared to sucrose intake has been shown in healthy men [<xref rid="B36-nutrients-08-00802" ref-type="bibr">36</xref>], and was explained by slower digestion of isomaltulose compared to sucrose [<xref rid="B16-nutrients-08-00802" ref-type="bibr">16</xref>]. Although GLP-1 response has been shown to be lower after pure fructose intake when compared with an equicaloric glucose load [<xref rid="B37-nutrients-08-00802" ref-type="bibr">37</xref>] SSB intake with isomaltulose that contains 50% fructose led to significantly higher GLP-1 release compared to maltodextrin-sucrose intake with only 12.5% fructose (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>). This indicates that a higher GLP-1 release with isomaltulose compared to maltodextrin-sucrose intake results from a slower degradation of the &#x003b1;-1,6 glycosidic bond of isomaltulose that leads to retarded resorption and a higher proportion of glucose reaching the distal part of the ileum where GLP-1 secreting L-cells are found [<xref rid="B16-nutrients-08-00802" ref-type="bibr">16</xref>,<xref rid="B38-nutrients-08-00802" ref-type="bibr">38</xref>]. Our findings are in line with the result of a recent study which has shown higher GLP-1 secretion with isomaltulose compared to sucrose intake in healthy men [<xref rid="B19-nutrients-08-00802" ref-type="bibr">19</xref>]. Postprandial vasodilatation is mediated by insulin signaling due to insulin-induced release of nitric oxide [<xref rid="B39-nutrients-08-00802" ref-type="bibr">39</xref>]. However, lower insulin response with isomaltulose intake resulted in similar vasodilatation compared to high insulin responses with maltodextrin-sucrose intake (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>). Since it has been demonstrated that GLP-1 per se has direct beneficial effects on endothelium-dependent vasodilatation in humans [<xref rid="B20-nutrients-08-00802" ref-type="bibr">20</xref>] higher GLP-1 secretion with low-GI isomaltulose intake may compensate lower insulin responses. </p><p>In type 2 diabetes, postprandial GLP-1 response after a mixed meal is strongly reduced, compared to healthy subjects [<xref rid="B40-nutrients-08-00802" ref-type="bibr">40</xref>] and may therefore contribute to a higher prevalence of hypertension in these patients. Although it is not clear if an inhibition of L-cell secretion or an increase in GLP-1 degradation contribute to the lower incretin effect in type 2 diabetes, the intake of low-GI isomaltulose has been shown to increase GLP-1 secretion compared to sucrose in type 2 diabetes [<xref rid="B41-nutrients-08-00802" ref-type="bibr">41</xref>] and may therefore improve postprandial vasodilatation. </p><p>Impaired endothelium-derived vasodilatation is a general finding in hypertension and it is suggested that defects in the NO system can induce hypertension [<xref rid="B42-nutrients-08-00802" ref-type="bibr">42</xref>]. Since vasodilatation via GLP-1 receptors in human endothelial cells also appears to be induced by increased NO production (for review see [<xref rid="B43-nutrients-08-00802" ref-type="bibr">43</xref>]), the present data suggest that consumption of SSBs with isomaltulose compared to conventional high-GI SSBs could improve postprandial vasodilatation in hypertension. </p></sec><sec id="sec4dot2-nutrients-08-00802"><title>4.2. Effect of GI Intervention on Low Physical Activity-Induced Changes in Glucose Metabolism and Arterial Stiffness</title><p>Low physical activity is an important risk factor for all-cause mortality [<xref rid="B44-nutrients-08-00802" ref-type="bibr">44</xref>]. Prolonged sitting of 3&#x02013;6 h leads to impaired endothelial function, i.e., a lower shear rate and flow mediated vasodilatation in the superficial femoral artery [<xref rid="B45-nutrients-08-00802" ref-type="bibr">45</xref>,<xref rid="B46-nutrients-08-00802" ref-type="bibr">46</xref>] and five days of bed rest in healthy subjects results in decreased endothelial function, arterial stiffening, increased diastolic blood pressure and development of insulin resistance and dyslipidemia [<xref rid="B24-nutrients-08-00802" ref-type="bibr">24</xref>,<xref rid="B47-nutrients-08-00802" ref-type="bibr">47</xref>]. However, in the present study BP and arterial stiffness were not affected by one week of low physical activity despite impaired insulin sensitivity and lipid profile (<xref ref-type="table" rid="nutrients-08-00802-t001">Table 1</xref> and <xref ref-type="table" rid="nutrients-08-00802-t002">Table 2</xref>).</p><p>Endothelial dysfunction also belongs to the metabolic abnormalities accompanying insulin resistance and type 2 diabetes (for review see [<xref rid="B11-nutrients-08-00802" ref-type="bibr">11</xref>]). Underlying mechanisms include the activation of protein kinase C, increased expression of adhesion molecules, production of endothelin, increased proliferation of endothelial cells and decreased production of nitric oxide (NO), e.g., induced by hyperglycemia (for review see [<xref rid="B48-nutrients-08-00802" ref-type="bibr">48</xref>]). This shift between vasodilator and vasoconstrictor actions of insulin is important for the pathophysiology of vascular dysfunction in insulin resistance [<xref rid="B13-nutrients-08-00802" ref-type="bibr">13</xref>]. Although the present data did not show impaired arterial stiffness with decreased IS in healthy men, an increase in arterial stiffness already occurs before the onset of type 2 diabetes in subjects with increased plasma glucose levels [<xref rid="B49-nutrients-08-00802" ref-type="bibr">49</xref>,<xref rid="B50-nutrients-08-00802" ref-type="bibr">50</xref>] and is also increased in obese and insulin resistant adolescents and young adults [<xref rid="B51-nutrients-08-00802" ref-type="bibr">51</xref>]. Although daylong glycemia did not show activity &#x000d7; GI effect, the fluctuation in glucose levels assessed by MAGE was significantly increased by high-GI SSB but not by low-GI SSB consumption during low physical activity (<xref ref-type="fig" rid="nutrients-08-00802-f003">Figure 3</xref>). Hyperglycemia-induced vascular damage is triggered by overproduction of superoxide by the mitochondrial electron-transport chain [<xref rid="B52-nutrients-08-00802" ref-type="bibr">52</xref>]. In addition, glycemic variability has been proposed to have more deleterious effects than sustained hyperglycemia because increments and decreases in glucose levels both increase oxidative stress in patients with type 2 diabetes [<xref rid="B53-nutrients-08-00802" ref-type="bibr">53</xref>,<xref rid="B54-nutrients-08-00802" ref-type="bibr">54</xref>]. However, higher glycemic variability during high-GI SSB consumption had no effect on arterial stiffness (<xref ref-type="table" rid="nutrients-08-00802-t003">Table 3</xref>). This may be due to a persistent protective effect of physical fitness in our habitually very active young men (i.e., &#x0003e;10,000 steps per day) because training reinforces the endogenic antioxidative capacity and results in a reduction in oxidative stress and improved endothelial function [<xref rid="B55-nutrients-08-00802" ref-type="bibr">55</xref>] whereas detraining has been shown to only gradually increase oxidative stress and systolic blood pressure over time [<xref rid="B56-nutrients-08-00802" ref-type="bibr">56</xref>]. </p><p>Intervention studies investigating the beneficial effect of low-GI diets on insulin sensitivity are limited to obese/overweight subjects with insulin resistance [<xref rid="B57-nutrients-08-00802" ref-type="bibr">57</xref>]. Our data provide evidence that intake of low-GI compared to high-GI SSB led to an attenuation of the impairment in glucose metabolism with low physical activity (<xref ref-type="table" rid="nutrients-08-00802-t002">Table 2</xref>). The better maintenance of glucose metabolism with low-GI isomaltulose could therefore contribute to preserve endothelial function in long-term. In line with this hypothesis, the results of a 6-month intervention indicate that a low-GI diet may be beneficial in reducing risk of coronary heart disease, including PWV and 24-h BP with concurrent lower insulin resistance compared to high-GI diet [<xref rid="B9-nutrients-08-00802" ref-type="bibr">9</xref>]. This result is supported by a 24-h intervention with a low-GI diet compared to a high-GI diet in normotensive women that has shown a lower 24-hour BP with low-GI diet [<xref rid="B58-nutrients-08-00802" ref-type="bibr">58</xref>]. In addition, 10% weight-loss with low vs. high glycemic load diets in young overweight and obese adults resulted in a higher reduction of BP [<xref rid="B8-nutrients-08-00802" ref-type="bibr">8</xref>].</p></sec><sec id="sec4dot3-nutrients-08-00802"><title>4.3. Study Limitations</title><p>Baseline fasting GLP-1 levels tended to be higher with low-GI intervention compared to high-GI intervention (<xref ref-type="fig" rid="nutrients-08-00802-f002">Figure 2</xref>). This may be an adaptation to the daily intake of isomaltulose-sweetened SSB during the inactive intervention period prior to the measurement. The ratio of glucose:fructose differed between both SSB interventions. Low-GI SSB with isomaltulose had a ratio of 50:50, whereas high-GI SSB with maltodextrin + sucrose had a glucose:fructose ratio of 87.5:12.5. Since our study only covers a short intervention period of one week in healthy people, the results are not transferable to chronic effects and groups of patients. The long-term effects of low-GI sugars on endothelial function and glucose metabolism therefore need to be investigated in subjects with impaired glucose tolerance and/or hypertension.</p></sec></sec><sec id="sec5-nutrients-08-00802"><title>5. Conclusions</title><p>One week of low physical activity led to impaired insulin sensitivity, while arterial stiffness was not affected. Positive effects of postprandial GLP-1 secretion with isomaltulose compared to maltodextrin-sucrose intake may contribute to postprandial vasodilatation. </p></sec></body><back><ack><title>Acknowledgments</title><p>Isomaltulose (Palatinose&#x02122;) was kindly provided by Beneo GmbH (Mannheim, Germany) free of charge. </p></ack><app-group><app id="app1-nutrients-08-00802"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:type="simple" xlink:href="http://www.mdpi.com/2072-6643/8/12/802/s1">http://www.mdpi.com/2072-6643/8/12/802/s1</uri>, Table S1: Composition of the diet stratified by activity, low-GI and high-GI intervention. </p><supplementary-material content-type="local-data" id="nutrients-08-00802-s001"><media xlink:href="nutrients-08-00802-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>A.B.-W., J.Ke. and J.Ka. designed the research; J.Ke. and J.Ka. conducted research; J.Ke., J.Ka., A.P. and A.B.-W. analyzed the data; J.Ke. and A.B.-W. wrote the paper; J.Ke. and A.B.-W. had primary responsibility for final content. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-08-00802"><label>1.</label><element-citation publication-type="webpage">
<person-group person-group-type="author"><collab>World Health Organization</collab></person-group>
<article-title>Reducing Consumption of Sugar-Sweetened Beverages to Reduce the Risk of Unhealthy Weight Gain in Adults</article-title>
<year>2014</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/elena/bbc/ssbs_adult_weight/en/">http://www.who.int/elena/bbc/ssbs_adult_weight/en/</ext-link></comment>
<date-in-citation>(accessed on 18 February 2016)</date-in-citation>
</element-citation></ref><ref id="B2-nutrients-08-00802"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Popkin</surname><given-names>B.M.</given-names></name><name><surname>Hawkes</surname><given-names>C.</given-names></name></person-group>
<article-title>Sweetening of the global diet, particularly beverages: Patterns, trends, and policy responses</article-title>
<source>Lancet Diabetes Endocrinol.</source>
<year>2015</year>
<volume>4</volume>
<fpage>174</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-8587(15)00419-2</pub-id>
<pub-id pub-id-type="pmid">26654575</pub-id></element-citation></ref><ref id="B3-nutrients-08-00802"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malik</surname><given-names>V.S.</given-names></name><name><surname>Hu</surname><given-names>F.B.</given-names></name></person-group>
<article-title>Sweeteners and risk of obesity and type 2 diabetes: The role of sugar-sweetened beverages</article-title>
<source>Curr. Diabetes Rep.</source>
<year>2012</year>
<volume>12</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1007/s11892-012-0259-6</pub-id>
<pub-id pub-id-type="pmid">22289979</pub-id></element-citation></ref><ref id="B4-nutrients-08-00802"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Te Morenga</surname><given-names>L.A.</given-names></name><name><surname>Howatson</surname><given-names>A.J.</given-names></name><name><surname>Jones</surname><given-names>R.M.</given-names></name><name><surname>Mann</surname><given-names>J.</given-names></name></person-group>
<article-title>Dietary sugars and cardiometabolic risk: Systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>2014</year>
<volume>100</volume>
<fpage>65</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.113.081521</pub-id>
<pub-id pub-id-type="pmid">24808490</pub-id></element-citation></ref><ref id="B5-nutrients-08-00802"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>I.J.</given-names></name><name><surname>Stamler</surname><given-names>J.</given-names></name><name><surname>van Horn</surname><given-names>L.</given-names></name><name><surname>Robertson</surname><given-names>C.E.</given-names></name><name><surname>Chan</surname><given-names>Q.</given-names></name><name><surname>Dyer</surname><given-names>A.R.</given-names></name><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Rodriguez</surname><given-names>B.L.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Daviglus</surname><given-names>M.L.</given-names></name><etal/></person-group>
<article-title>Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: International study of macro/micronutrients and blood pressure</article-title>
<source>Hypertension</source>
<year>2011</year>
<volume>57</volume>
<fpage>695</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.110.165456</pub-id>
<pub-id pub-id-type="pmid">21357284</pub-id></element-citation></ref><ref id="B6-nutrients-08-00802"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Welsh</surname><given-names>J.A.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Cunningham</surname><given-names>S.A.</given-names></name><name><surname>Vos</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents</article-title>
<source>Circulation</source>
<year>2011</year>
<volume>123</volume>
<fpage>249</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.972166</pub-id>
<pub-id pub-id-type="pmid">21220734</pub-id></element-citation></ref><ref id="B7-nutrients-08-00802"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duffey</surname><given-names>K.J.</given-names></name><name><surname>Huybrechts</surname><given-names>I.</given-names></name><name><surname>Mouratidou</surname><given-names>T.</given-names></name><name><surname>Libuda</surname><given-names>L.</given-names></name><name><surname>Kersting</surname><given-names>M.</given-names></name><name><surname>De Vriendt</surname><given-names>T.</given-names></name><name><surname>Gottrand</surname><given-names>F.</given-names></name><name><surname>Widhalm</surname><given-names>K.</given-names></name><name><surname>Dallongeville</surname><given-names>J.</given-names></name><name><surname>Hallstr&#x000f6;m</surname><given-names>L.</given-names></name><etal/></person-group>
<article-title>Beverage consumption among European adolescents in the HELENA study</article-title>
<source>Eur. J. Clin. Nutr.</source>
<year>2012</year>
<volume>66</volume>
<fpage>244</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1038/ejcn.2011.166</pub-id>
<pub-id pub-id-type="pmid">21952695</pub-id></element-citation></ref><ref id="B8-nutrients-08-00802"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pereira</surname><given-names>M.A.</given-names></name><name><surname>Swain</surname><given-names>J.</given-names></name><name><surname>Goldfine</surname><given-names>A.B.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Ludwig</surname><given-names>D.S.</given-names></name></person-group>
<article-title>Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss</article-title>
<source>JAMA</source>
<year>2004</year>
<volume>292</volume>
<fpage>2482</fpage>
<lpage>2490</lpage>
<pub-id pub-id-type="doi">10.1001/jama.292.20.2482</pub-id>
<pub-id pub-id-type="pmid">15562127</pub-id></element-citation></ref><ref id="B9-nutrients-08-00802"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Philippou</surname><given-names>E.</given-names></name><name><surname>Bovill-Taylor</surname><given-names>C.</given-names></name><name><surname>Rajkumar</surname><given-names>C.</given-names></name><name><surname>Vampa</surname><given-names>M.L.</given-names></name><name><surname>Ntatsaki</surname><given-names>E.</given-names></name><name><surname>Brynes</surname><given-names>A.E.</given-names></name><name><surname>Hickson</surname><given-names>M.</given-names></name><name><surname>Frost</surname><given-names>G.S.</given-names></name></person-group>
<article-title>Preliminary report: The effect of a 6-month dietary glycemic index manipulation in addition to healthy eating advice and weight loss on arterial compliance and 24-hour ambulatory blood pressure in men: A pilot study</article-title>
<source>Metabolism</source>
<year>2009</year>
<volume>58</volume>
<fpage>1703</fpage>
<lpage>1708</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2009.05.026</pub-id>
<pub-id pub-id-type="pmid">19604522</pub-id></element-citation></ref><ref id="B10-nutrients-08-00802"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malik</surname><given-names>V.</given-names></name><name><surname>Popkin</surname><given-names>B.</given-names></name><name><surname>Bray</surname><given-names>G.</given-names></name><name><surname>Despr&#x000e9;s</surname><given-names>J.-P.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name></person-group>
<article-title>Sugar Sweetened Beverages, Obesity, Type 2 Diabetes and Cardiovascular Disease risk</article-title>
<source>Circulation</source>
<year>2010</year>
<volume>121</volume>
<fpage>1356</fpage>
<lpage>1364</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.876185</pub-id>
<pub-id pub-id-type="pmid">20308626</pub-id></element-citation></ref><ref id="B11-nutrients-08-00802"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rask-Madsen</surname><given-names>C.</given-names></name><name><surname>King</surname><given-names>G.L.</given-names></name></person-group>
<article-title>Mechanisms of Disease: Endothelial dysfunction in insulin resistance and diabetes</article-title>
<source>Nat. Clin. Pract. Endocrinol. Metab.</source>
<year>2007</year>
<volume>3</volume>
<fpage>46</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1038/ncpendmet0366</pub-id>
<pub-id pub-id-type="pmid">17179929</pub-id></element-citation></ref><ref id="B12-nutrients-08-00802"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>G.</given-names></name><name><surname>Nystrom</surname><given-names>F.H.</given-names></name><name><surname>Ravichandran</surname><given-names>L.V.</given-names></name><name><surname>Cong</surname><given-names>L.N.</given-names></name><name><surname>Kirby</surname><given-names>M.</given-names></name><name><surname>Mostowski</surname><given-names>H.</given-names></name><name><surname>Quon</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells</article-title>
<source>Circulation</source>
<year>2000</year>
<volume>101</volume>
<fpage>1539</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.101.13.1539</pub-id>
<pub-id pub-id-type="pmid">10747347</pub-id></element-citation></ref><ref id="B13-nutrients-08-00802"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Montagnani</surname><given-names>M.</given-names></name><name><surname>Kwang</surname><given-names>K.K.</given-names></name><name><surname>Quon</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms</article-title>
<source>Circulation</source>
<year>2006</year>
<volume>113</volume>
<fpage>1888</fpage>
<lpage>1904</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.563213</pub-id>
<pub-id pub-id-type="pmid">16618833</pub-id></element-citation></ref><ref id="B14-nutrients-08-00802"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feldman</surname><given-names>R.D.</given-names></name><name><surname>Bierbrier</surname><given-names>G.S.</given-names></name></person-group>
<article-title>Insulin-mediated vasodilation: Impairment with increased blood pressure and body mass</article-title>
<source>Lancet</source>
<year>1993</year>
<volume>342</volume>
<fpage>707</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1016/0140-6736(93)91708-T</pub-id>
<pub-id pub-id-type="pmid">8103822</pub-id></element-citation></ref><ref id="B15-nutrients-08-00802"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kahlh&#x000f6;fer</surname><given-names>J.</given-names></name><name><surname>Karschin</surname><given-names>J.</given-names></name><name><surname>Silberhorn-B&#x000fc;hler</surname><given-names>H.</given-names></name><name><surname>Breusing</surname><given-names>N.</given-names></name><name><surname>Bosy-Westphal</surname><given-names>A.</given-names></name></person-group>
<article-title>Effect of low-glycemic-sugar-sweetened beverages on glucose metabolism and macronutrient oxidation in healthy men</article-title>
<source>Int. J. Obes.</source>
<year>2016</year>
<volume>40</volume>
<fpage>990</fpage>
<lpage>997</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2016.25</pub-id>
<pub-id pub-id-type="pmid">26869244</pub-id></element-citation></ref><ref id="B16-nutrients-08-00802"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lina</surname><given-names>B.A.R.</given-names></name><name><surname>Jonker</surname><given-names>D.</given-names></name><name><surname>Kozianowski</surname><given-names>G.</given-names></name></person-group>
<article-title>Isomaltulose (Palatinose): A review of biological and toxicological studies</article-title>
<source>Food Chem. Toxicol.</source>
<year>2002</year>
<volume>40</volume>
<fpage>1375</fpage>
<lpage>1381</lpage>
<pub-id pub-id-type="doi">10.1016/S0278-6915(02)00105-9</pub-id>
<pub-id pub-id-type="pmid">12387299</pub-id></element-citation></ref><ref id="B17-nutrients-08-00802"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>F.</given-names></name><name><surname>Foster-Powell</surname><given-names>K.</given-names></name><name><surname>Brand-Miller</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Glycemic Load Values: 2008</article-title>
<source>Diabetes Care</source>
<year>2008</year>
<volume>31</volume>
<fpage>2281</fpage>
<lpage>2283</lpage>
<pub-id pub-id-type="doi">10.2337/dc08-1239</pub-id>
<pub-id pub-id-type="pmid">18835944</pub-id></element-citation></ref><ref id="B18-nutrients-08-00802"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Nieuwenhoven</surname><given-names>M.A.</given-names></name><name><surname>Brouns</surname><given-names>F.</given-names></name><name><surname>Kovacs</surname><given-names>E.M.R.</given-names></name></person-group>
<article-title>The effect of two sports drinks and water on GI complaints and performance during an 18-km run</article-title>
<source>Int. J. Sports Med.</source>
<year>2005</year>
<volume>26</volume>
<fpage>281</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1055/s-2004-820931</pub-id>
<pub-id pub-id-type="pmid">15795812</pub-id></element-citation></ref><ref id="B19-nutrients-08-00802"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Miyagawa</surname><given-names>J.I.</given-names></name><name><surname>Miuchi</surname><given-names>M.</given-names></name><name><surname>Nagai</surname><given-names>E.</given-names></name><name><surname>Konishi</surname><given-names>K.</given-names></name><name><surname>Matsuo</surname><given-names>T.</given-names></name><name><surname>Tokuda</surname><given-names>M.</given-names></name><name><surname>Kusunoki</surname><given-names>Y.</given-names></name><name><surname>Ochi</surname><given-names>H.</given-names></name><name><surname>Murai</surname><given-names>K.</given-names></name><etal/></person-group>
<article-title>Effects of the naturally-occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non-obese subjects</article-title>
<source>J. Diabetes Investig.</source>
<year>2013</year>
<volume>4</volume>
<fpage>281</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1111/jdi.12045</pub-id>
<pub-id pub-id-type="pmid">24843667</pub-id></element-citation></ref><ref id="B20-nutrients-08-00802"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basu</surname><given-names>A.</given-names></name><name><surname>Charkoudian</surname><given-names>N.</given-names></name><name><surname>Schrage</surname><given-names>W.</given-names></name><name><surname>Rizza R</surname><given-names>A.</given-names></name><name><surname>Basu</surname><given-names>R.</given-names></name><name><surname>Joyner</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Beneficial effects of GLP-1 on endothelial function in humans: Dampening by glyburide but not by glimepiride</article-title>
<source>Am. J. Physiol. Endocrinol. Metab.</source>
<year>2007</year>
<volume>293</volume>
<fpage>E1289</fpage>
<lpage>E1295</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00373.2007</pub-id>
<pub-id pub-id-type="pmid">17711996</pub-id></element-citation></ref><ref id="B21-nutrients-08-00802"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nystr&#x000f6;m</surname><given-names>T.</given-names></name><name><surname>Gutniak</surname><given-names>M.K.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Holst</surname><given-names>J.J.</given-names></name><name><surname>Ahr&#x000e9;n</surname><given-names>B.</given-names></name><name><surname>Sj&#x000f6;holm</surname><given-names>&#x000c5;.</given-names></name></person-group>
<article-title>Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease</article-title>
<source>Am. J. Physiol. Endocrinol. Metab.</source>
<year>2004</year>
<volume>287</volume>
<fpage>E1209</fpage>
<lpage>E1215</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00237.2004</pub-id>
<pub-id pub-id-type="pmid">15353407</pub-id></element-citation></ref><ref id="B22-nutrients-08-00802"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krogh-Madsen</surname><given-names>R.</given-names></name><name><surname>Thyfault</surname><given-names>J.P.</given-names></name><name><surname>Broholm</surname><given-names>C.</given-names></name><name><surname>Mortensen</surname><given-names>O.H.</given-names></name><name><surname>Olsen</surname><given-names>R.H.</given-names></name><name><surname>Mounier</surname><given-names>R.</given-names></name><name><surname>Plomgaard</surname><given-names>P.</given-names></name><name><surname>van Hall</surname><given-names>G.</given-names></name><name><surname>Booth</surname><given-names>F.W.</given-names></name><name><surname>Pedersen</surname><given-names>B.K.</given-names></name></person-group>
<article-title>A 2-week reduction of ambulatory activity attenuates peripheral insulin sensitivity</article-title>
<source>J. Appl. Physiol.</source>
<year>2010</year>
<volume>108</volume>
<fpage>1034</fpage>
<lpage>1040</lpage>
<pub-id pub-id-type="doi">10.1152/japplphysiol.00977.2009</pub-id>
<pub-id pub-id-type="pmid">20044474</pub-id></element-citation></ref><ref id="B23-nutrients-08-00802"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gomez-Marcos</surname><given-names>M.A.</given-names></name><name><surname>Recio-Rodr&#x000ed;guez</surname><given-names>J.I.</given-names></name><name><surname>Patino-Alonso</surname><given-names>M.C.</given-names></name><name><surname>Agudo-Conde</surname><given-names>C.</given-names></name><name><surname>Lasaosa-Medina</surname><given-names>L.</given-names></name><name><surname>Rodriguez-Sanchez</surname><given-names>E.</given-names></name><name><surname>Maderuelo-Fernandez</surname><given-names>J.A.</given-names></name><name><surname>Garc&#x000ed;a-Ortiz</surname><given-names>L.</given-names></name><collab>EVIDENT Group</collab></person-group>
<article-title>Relationship between objectively measured physical activity and vascular structure and function in adults</article-title>
<source>Atherosclerosis</source>
<year>2014</year>
<volume>234</volume>
<fpage>366</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.02.028</pub-id>
<pub-id pub-id-type="pmid">24742874</pub-id></element-citation></ref><ref id="B24-nutrients-08-00802"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nosova</surname><given-names>E.V.</given-names></name><name><surname>Yen</surname><given-names>P.</given-names></name><name><surname>Chong</surname><given-names>K.C.</given-names></name><name><surname>Alley</surname><given-names>H.F.</given-names></name><name><surname>Stock</surname><given-names>E.O.</given-names></name><name><surname>Quinn</surname><given-names>A.</given-names></name><name><surname>Hellmann</surname><given-names>J.</given-names></name><name><surname>Conte</surname><given-names>M.S.</given-names></name><name><surname>Owens</surname><given-names>C.D.</given-names></name><name><surname>Spite</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>Short-term physical inactivity impairs vascular function</article-title>
<source>J. Surg. Res.</source>
<year>2014</year>
<volume>190</volume>
<fpage>672</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="doi">10.1016/j.jss.2014.02.001</pub-id>
<pub-id pub-id-type="pmid">24630521</pub-id></element-citation></ref><ref id="B25-nutrients-08-00802"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stephens</surname><given-names>B.R.</given-names></name><name><surname>Granados</surname><given-names>K.</given-names></name><name><surname>Zderic</surname><given-names>T.W.</given-names></name><name><surname>Hamilton</surname><given-names>M.T.</given-names></name><name><surname>Braun</surname><given-names>B.</given-names></name></person-group>
<article-title>Effects of 1 day of inactivity on insulin action in healthy men and women: Interaction with energy intake</article-title>
<source>Metabolism</source>
<year>2011</year>
<volume>60</volume>
<fpage>941</fpage>
<lpage>949</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2010.08.014</pub-id>
<pub-id pub-id-type="pmid">21067784</pub-id></element-citation></ref><ref id="B26-nutrients-08-00802"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tudor-Locke</surname><given-names>C.</given-names></name><name><surname>Craig</surname><given-names>C.L.</given-names></name><name><surname>Brown</surname><given-names>W.J.</given-names></name><name><surname>Clemes</surname><given-names>S.A.</given-names></name><name><surname>De Cocker</surname><given-names>K.</given-names></name><name><surname>Giles-Corti</surname><given-names>B.</given-names></name><name><surname>Hatano</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>S.</given-names></name><name><surname>Matsudo</surname><given-names>S.M.</given-names></name><name><surname>Mutrie</surname><given-names>N.</given-names></name><etal/></person-group>
<article-title>How many steps/day are enough? For adults</article-title>
<source>Int. J. Behav. Nutr. Phys. Act.</source>
<year>2011</year>
<volume>8</volume>
<fpage>79</fpage>
<pub-id pub-id-type="doi">10.1186/1479-5868-8-79</pub-id>
<pub-id pub-id-type="pmid">21798015</pub-id></element-citation></ref><ref id="B27-nutrients-08-00802"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mark</surname><given-names>T.</given-names></name></person-group>
<article-title>Standardized use of the terms &#x0201c;sedentary&#x0201d; and &#x0201c;sedentary behaviours&#x0201d;</article-title>
<source>Appl. Physiol. Nutr. Metab.</source>
<year>2012</year>
<volume>37</volume>
<fpage>540</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="pmid">22540258</pub-id></element-citation></ref><ref id="B28-nutrients-08-00802"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hickson</surname><given-names>S.S.</given-names></name><name><surname>Butlin</surname><given-names>M.</given-names></name><name><surname>Broad</surname><given-names>J.</given-names></name><name><surname>Avolio</surname><given-names>A.P.</given-names></name><name><surname>Wilkinson</surname><given-names>I.B.</given-names></name><name><surname>McEniery</surname><given-names>C.M.</given-names></name></person-group>
<article-title>Validity and repeatability of the Vicorder apparatus: A comparison with the SphygmoCor device</article-title>
<source>Hypertens. Res.</source>
<year>2009</year>
<volume>32</volume>
<fpage>1079</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1038/hr.2009.154</pub-id>
<pub-id pub-id-type="pmid">19779487</pub-id></element-citation></ref><ref id="B29-nutrients-08-00802"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGreevy</surname><given-names>C.</given-names></name><name><surname>Barry</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name></person-group>
<article-title>Repeatability of the measurement of aortic pulse wave velocity (aPWV) in the clinical assessment of arterial stiffness in community-dwelling older patients using the Vicorder<sup>&#x000ae;</sup> device</article-title>
<source>Scand. J. Clin. Lab. Investig.</source>
<year>2013</year>
<volume>73</volume>
<fpage>269</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.3109/00365513.2013.770162</pub-id>
<pub-id pub-id-type="pmid">23544457</pub-id></element-citation></ref><ref id="B30-nutrients-08-00802"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGreevy</surname><given-names>C.</given-names></name><name><surname>Barry</surname><given-names>M.</given-names></name><name><surname>Davenport</surname><given-names>C.</given-names></name><name><surname>Byrne</surname><given-names>B.</given-names></name><name><surname>Donaghy</surname><given-names>C.</given-names></name><name><surname>Collier</surname><given-names>G.</given-names></name><name><surname>Tormey</surname><given-names>W.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Bennett</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name></person-group>
<article-title>The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population</article-title>
<source>J. Am. Soc. Hypertens.</source>
<year>2014</year>
<volume>9</volume>
<fpage>176</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.jash.2014.12.019</pub-id>
<pub-id pub-id-type="pmid">25681237</pub-id></element-citation></ref><ref id="B31-nutrients-08-00802"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Service</surname><given-names>F.J.</given-names></name><name><surname>Molnar</surname><given-names>G.D.</given-names></name><name><surname>Rosevear</surname><given-names>J.W.</given-names></name><name><surname>Ackerman</surname><given-names>E.</given-names></name><name><surname>Gatewood</surname><given-names>L.C.</given-names></name><name><surname>Taylor</surname><given-names>W.F.</given-names></name></person-group>
<article-title>Mean amplitude of glycemic excursions, a measure of diabetic instability</article-title>
<source>Diabetes</source>
<year>1970</year>
<volume>19</volume>
<fpage>644</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.2337/diab.19.9.644</pub-id>
<pub-id pub-id-type="pmid">5469118</pub-id></element-citation></ref><ref id="B32-nutrients-08-00802"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Standl</surname><given-names>E.</given-names></name><name><surname>Schnell</surname><given-names>O.</given-names></name><name><surname>Ceriello</surname><given-names>A.</given-names></name></person-group>
<article-title>Postprandial Hyperglycemia and Glycemic Variability</article-title>
<source>Diabetes Care</source>
<year>2011</year>
<volume>34</volume>
<fpage>S120</fpage>
<lpage>S127</lpage>
<pub-id pub-id-type="doi">10.2337/dc11-s206</pub-id>
<pub-id pub-id-type="pmid">21525442</pub-id></element-citation></ref><ref id="B33-nutrients-08-00802"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matthews</surname><given-names>D.R.</given-names></name><name><surname>Hosker</surname><given-names>J.P.</given-names></name><name><surname>Rudenski</surname><given-names>A.S.</given-names></name><name><surname>Naylor</surname><given-names>B.A.</given-names></name><name><surname>Treacher</surname><given-names>D.F.</given-names></name><name><surname>Turner</surname><given-names>R.C.</given-names></name></person-group>
<article-title>Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title>
<source>Diabetologia</source>
<year>1985</year>
<volume>28</volume>
<fpage>412</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1007/BF00280883</pub-id>
<pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="B34-nutrients-08-00802"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>M.</given-names></name><name><surname>DeFronzo</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp</article-title>
<source>Diabetes Care</source>
<year>1999</year>
<volume>22</volume>
<fpage>1462</fpage>
<lpage>1470</lpage>
<pub-id pub-id-type="doi">10.2337/diacare.22.9.1462</pub-id>
<pub-id pub-id-type="pmid">10480510</pub-id></element-citation></ref><ref id="B35-nutrients-08-00802"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matthews</surname><given-names>J.N.</given-names></name><name><surname>Altman</surname><given-names>D.G.</given-names></name><name><surname>Campbell</surname><given-names>M.J.</given-names></name><name><surname>Royston</surname><given-names>P.</given-names></name></person-group>
<article-title>Analysis of serial measurements in medical research</article-title>
<source>BMJ</source>
<year>1990</year>
<volume>300</volume>
<fpage>230</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.300.6719.230</pub-id>
<pub-id pub-id-type="pmid">2106931</pub-id></element-citation></ref><ref id="B36-nutrients-08-00802"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>I.</given-names></name><name><surname>Daniel</surname><given-names>J.W.</given-names></name></person-group>
<article-title>The bio-availability of isomaltulose in man and rat</article-title>
<source>Nutr. Rep. Int.</source>
<year>1983</year>
<volume>28</volume>
<fpage>1083</fpage>
<lpage>1090</lpage>
</element-citation></ref><ref id="B37-nutrients-08-00802"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kong</surname><given-names>M.F.</given-names></name><name><surname>Chapman</surname><given-names>I.</given-names></name><name><surname>Goble</surname><given-names>E.</given-names></name><name><surname>Wishart</surname><given-names>J.</given-names></name><name><surname>Wittert</surname><given-names>G.</given-names></name><name><surname>Morris</surname><given-names>H.</given-names></name><name><surname>Horowitz</surname><given-names>M.</given-names></name></person-group>
<article-title>Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects</article-title>
<source>Peptides</source>
<year>1999</year>
<volume>20</volume>
<fpage>545</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1016/S0196-9781(99)00006-6</pub-id>
<pub-id pub-id-type="pmid">10465505</pub-id></element-citation></ref><ref id="B38-nutrients-08-00802"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baggio</surname><given-names>L.L.</given-names></name><name><surname>Drucker</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Biology of Incretins: GLP-1 and GIP</article-title>
<source>Gastroenterology</source>
<year>2007</year>
<volume>132</volume>
<fpage>2131</fpage>
<lpage>2157</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2007.03.054</pub-id>
<pub-id pub-id-type="pmid">17498508</pub-id></element-citation></ref><ref id="B39-nutrients-08-00802"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scherrer</surname><given-names>U.</given-names></name><name><surname>Randin</surname><given-names>D.</given-names></name><name><surname>Vollenweider</surname><given-names>P.</given-names></name><name><surname>Vollenweider</surname><given-names>L.</given-names></name><name><surname>Nicod</surname><given-names>P.</given-names></name></person-group>
<article-title>Nitric oxide release accounts for insulin&#x02019;s vascular effects in humans</article-title>
<source>J. Clin. Investig.</source>
<year>1994</year>
<volume>94</volume>
<fpage>2511</fpage>
<lpage>2515</lpage>
<pub-id pub-id-type="doi">10.1172/JCI117621</pub-id>
<pub-id pub-id-type="pmid">7989610</pub-id></element-citation></ref><ref id="B40-nutrients-08-00802"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vilsb&#x000f8;ll</surname><given-names>T.</given-names></name><name><surname>Krarup</surname><given-names>T.</given-names></name><name><surname>Deacon</surname><given-names>C.F.</given-names></name><name><surname>Madsbad</surname><given-names>S.</given-names></name><name><surname>Holst</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients</article-title>
<source>Diabetes</source>
<year>2001</year>
<volume>50</volume>
<fpage>609</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.50.3.609</pub-id>
<pub-id pub-id-type="pmid">11246881</pub-id></element-citation></ref><ref id="B41-nutrients-08-00802"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ang</surname><given-names>M.</given-names></name><name><surname>Linn</surname><given-names>T.</given-names></name></person-group>
<article-title>Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: A randomized trial 1&#x02013;3</article-title>
<source>Am. J. Clin. Nutr.</source>
<year>2014</year>
<volume>100</volume>
<fpage>1059</fpage>
<lpage>1068</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.113.076638</pub-id>
<pub-id pub-id-type="pmid">25030779</pub-id></element-citation></ref><ref id="B42-nutrients-08-00802"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lind</surname><given-names>L.</given-names></name></person-group>
<article-title>Endothelium-dependent Vasodilation in Hypertension: A Review</article-title>
<source>Blood Press.</source>
<year>2000</year>
<volume>9</volume>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1080/080370500439362</pub-id>
<pub-id pub-id-type="pmid">10854002</pub-id></element-citation></ref><ref id="B43-nutrients-08-00802"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ussher</surname><given-names>J.R.</given-names></name><name><surname>Drucker</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Cardiovascular biology of the incretin system</article-title>
<source>Endocr. Rev.</source>
<year>2012</year>
<volume>33</volume>
<fpage>187</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1210/er.2011-1052</pub-id>
<pub-id pub-id-type="pmid">22323472</pub-id></element-citation></ref><ref id="B44-nutrients-08-00802"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blair</surname><given-names>S.N.</given-names></name><name><surname>Kohl</surname><given-names>H.W.</given-names></name><name><surname>Paffenbarger</surname><given-names>R.S.</given-names></name><name><surname>Clark</surname><given-names>D.G.</given-names></name><name><surname>Cooper</surname><given-names>K.H.</given-names></name><name><surname>Gibbons</surname><given-names>L.W.</given-names></name></person-group>
<article-title>Physical fitness and all-cause mortality: A prospective study of healthy men and women</article-title>
<source>JAMA</source>
<year>1989</year>
<volume>262</volume>
<fpage>2395</fpage>
<lpage>2401</lpage>
<pub-id pub-id-type="doi">10.1001/jama.1989.03430170057028</pub-id>
<pub-id pub-id-type="pmid">2795824</pub-id></element-citation></ref><ref id="B45-nutrients-08-00802"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Restaino</surname><given-names>R.M.</given-names></name><name><surname>Holwerda</surname><given-names>S.W.</given-names></name><name><surname>Credeur</surname><given-names>D.P.</given-names></name><name><surname>Fadel</surname><given-names>P.J.</given-names></name><name><surname>Padilla</surname><given-names>J.</given-names></name></person-group>
<article-title>Impact of prolonged sitting on lower and upper limb micro- and macrovascular dilator function</article-title>
<source>Exp. Physiol.</source>
<year>2015</year>
<volume>100</volume>
<fpage>829</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="doi">10.1113/EP085238</pub-id>
<pub-id pub-id-type="pmid">25929229</pub-id></element-citation></ref><ref id="B46-nutrients-08-00802"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thosar</surname><given-names>S.S.</given-names></name><name><surname>Bielko</surname><given-names>S.L.</given-names></name><name><surname>Mather</surname><given-names>K.J.</given-names></name><name><surname>Johnston</surname><given-names>J.D.</given-names></name><name><surname>Wallace</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Effect of prolonged sitting and breaks in sitting time on endothelial function</article-title>
<source>Med. Sci. Sports Exerc.</source>
<year>2015</year>
<volume>47</volume>
<fpage>843</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1249/MSS.0000000000000479</pub-id>
<pub-id pub-id-type="pmid">25137367</pub-id></element-citation></ref><ref id="B47-nutrients-08-00802"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamburg</surname><given-names>N.M.</given-names></name><name><surname>McMackin</surname><given-names>C.J.</given-names></name><name><surname>Huang</surname><given-names>A.L.</given-names></name><name><surname>Shenouda</surname><given-names>S.M.</given-names></name><name><surname>Widlansky</surname><given-names>M.E.</given-names></name><name><surname>Schulz</surname><given-names>E.</given-names></name><name><surname>Gokce</surname><given-names>N.</given-names></name><name><surname>Ruderman</surname><given-names>N.B.</given-names></name><name><surname>Keaney</surname><given-names>J.F.</given-names></name><name><surname>Vita</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers</article-title>
<source>Arterioscler. Thromb. Vasc. Biol.</source>
<year>2007</year>
<volume>27</volume>
<fpage>2650</fpage>
<lpage>2656</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.107.153288</pub-id>
<pub-id pub-id-type="pmid">17932315</pub-id></element-citation></ref><ref id="B48-nutrients-08-00802"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lefebvre</surname><given-names>P.J.</given-names></name><name><surname>Scheen</surname><given-names>A.J.</given-names></name></person-group>
<article-title>The postprandial state and risk of cardiovascular disease</article-title>
<source>Diabet. Med.</source>
<year>1998</year>
<volume>15</volume>
<fpage>S63</fpage>
<lpage>S68</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(1998120)15:4+&#x0003c;S63::AID-DIA737&#x0003e;3.3.CO;2-Z</pub-id>
<pub-id pub-id-type="pmid">9868996</pub-id></element-citation></ref><ref id="B49-nutrients-08-00802"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henry</surname><given-names>R.M.A.</given-names></name><name><surname>Kostense</surname><given-names>P.J.</given-names></name><name><surname>Spijkerman</surname><given-names>A.M.W.</given-names></name><name><surname>Dekker</surname><given-names>J.M.</given-names></name><name><surname>Nijpels</surname><given-names>G.</given-names></name><name><surname>Heine</surname><given-names>R.J.</given-names></name><name><surname>Kamp</surname><given-names>O.</given-names></name><name><surname>Westerhof</surname><given-names>N.</given-names></name><name><surname>Bouter</surname><given-names>L.M.</given-names></name><name><surname>Stehouwer</surname><given-names>C.D.</given-names></name></person-group>
<article-title>Arterial stiffness increases with deteriorating glucose tolerance status: The Hoorn study</article-title>
<source>Circulation</source>
<year>2003</year>
<volume>107</volume>
<fpage>2089</fpage>
<lpage>2095</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.0000065222.34933.FC</pub-id>
<pub-id pub-id-type="pmid">12695300</pub-id></element-citation></ref><ref id="B50-nutrients-08-00802"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>H.</given-names></name><name><surname>Saitoh</surname><given-names>S.</given-names></name><name><surname>Takagi</surname><given-names>S.</given-names></name><name><surname>Ohata</surname><given-names>J.</given-names></name><name><surname>Isobe</surname><given-names>T.</given-names></name><name><surname>Kikuchi</surname><given-names>Y.</given-names></name><name><surname>Takeuchi</surname><given-names>H.</given-names></name><name><surname>Shimamoto</surname><given-names>K.</given-names></name></person-group>
<article-title>Pulse Wave Velocity as an Indicator of Atherosclerosis in Impaired Fasting Glucose</article-title>
<source>Diabetes Care</source>
<year>2003</year>
<volume>26</volume>
<fpage>437</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="doi">10.2337/diacare.26.2.437</pub-id>
<pub-id pub-id-type="pmid">12547876</pub-id></element-citation></ref><ref id="B51-nutrients-08-00802"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urbina</surname><given-names>E.M.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Khoury</surname><given-names>P.R.</given-names></name><name><surname>Martin</surname><given-names>L.J.</given-names></name><name><surname>Dolan</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Insulin resistance and arterial stiffness in healthy adolescents and young adults</article-title>
<source>Diabetologia</source>
<year>2012</year>
<volume>55</volume>
<fpage>625</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-011-2412-1</pub-id>
<pub-id pub-id-type="pmid">22193511</pub-id></element-citation></ref><ref id="B52-nutrients-08-00802"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brownlee</surname><given-names>M.</given-names></name></person-group>
<article-title>Biochemistry and molecular cell biology of diabetic complications</article-title>
<source>Nature</source>
<year>2001</year>
<volume>414</volume>
<fpage>813</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1038/414813a</pub-id>
<pub-id pub-id-type="pmid">11742414</pub-id></element-citation></ref><ref id="B53-nutrients-08-00802"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A.</given-names></name><name><surname>Cavarape</surname><given-names>A.</given-names></name><name><surname>Martinelli</surname><given-names>L.</given-names></name><name><surname>Da Ros</surname><given-names>R.</given-names></name><name><surname>Marra</surname><given-names>G.</given-names></name><name><surname>Quagliaro</surname><given-names>L.</given-names></name><name><surname>Piconi</surname><given-names>L.</given-names></name><name><surname>Assaloni</surname><given-names>R.</given-names></name><name><surname>Motz</surname><given-names>E.</given-names></name></person-group>
<article-title>The post-prandial state in Type 2 diabetes and endothelial dysfunction: Effects of insulin aspart</article-title>
<source>Diabet. Med.</source>
<year>2004</year>
<volume>21</volume>
<fpage>171</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1111/j.1464-5491.2004.01101.x</pub-id>
<pub-id pub-id-type="pmid">14984453</pub-id></element-citation></ref><ref id="B54-nutrients-08-00802"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monnier</surname><given-names>L.</given-names></name><name><surname>Mas</surname><given-names>E.</given-names></name><name><surname>Ginet</surname><given-names>C.</given-names></name><name><surname>Michel</surname><given-names>F.</given-names></name><name><surname>Villon</surname><given-names>L.</given-names></name><name><surname>Cristol</surname><given-names>J.-P.</given-names></name><name><surname>Colette</surname><given-names>C.</given-names></name></person-group>
<article-title>Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes</article-title>
<source>JAMA</source>
<year>2006</year>
<volume>295</volume>
<fpage>1681</fpage>
<lpage>1687</lpage>
<pub-id pub-id-type="doi">10.1001/jama.295.14.1681</pub-id>
<pub-id pub-id-type="pmid">16609090</pub-id></element-citation></ref><ref id="B55-nutrients-08-00802"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brinkmann</surname><given-names>C.</given-names></name><name><surname>Schwinger</surname><given-names>R.H.G.</given-names></name><name><surname>Brixius</surname><given-names>K.</given-names></name></person-group>
<article-title>Physical activity and endothelial dysfunction in type 2 diabetic patients: The role of nitric oxide and oxidative stress</article-title>
<source>Wien Med. Wochenschr.</source>
<year>2011</year>
<volume>161</volume>
<fpage>305</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1007/s10354-011-0868-8</pub-id>
<pub-id pub-id-type="pmid">21360292</pub-id></element-citation></ref><ref id="B56-nutrients-08-00802"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kilic-Erkek</surname><given-names>O.</given-names></name><name><surname>Kilic-Toprak</surname><given-names>E.</given-names></name><name><surname>Caliskan</surname><given-names>S.</given-names></name><name><surname>Ekbic</surname><given-names>Y.</given-names></name><name><surname>Akbudak</surname><given-names>I.H.</given-names></name><name><surname>Kucukatay</surname><given-names>V.</given-names></name><name><surname>Bor-Kucukatay</surname><given-names>M.</given-names></name></person-group>
<article-title>Detraining reverses exercise-induced improvement in blood pressure associated with decrements of oxidative stress in various tissues in spontaneously hypertensive rats</article-title>
<source>Mol. Cell. Biochem.</source>
<year>2016</year>
<volume>412</volume>
<fpage>209</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-015-2627-4</pub-id>
<pub-id pub-id-type="pmid">26708216</pub-id></element-citation></ref><ref id="B57-nutrients-08-00802"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Colagiuri</surname><given-names>S.</given-names></name></person-group>
<article-title>Health potential of a low glycaemic index diet</article-title>
<source>BMJ</source>
<year>2015</year>
<volume>350</volume>
<fpage>h2267</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.h2267</pub-id>
<pub-id pub-id-type="pmid">25951826</pub-id></element-citation></ref><ref id="B58-nutrients-08-00802"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hosseininasab</surname><given-names>M.</given-names></name><name><surname>Norouzy</surname><given-names>A.</given-names></name><name><surname>Nematy</surname><given-names>M.</given-names></name><name><surname>Bonakdaran</surname><given-names>S.</given-names></name></person-group>
<article-title>Low-Glycemic-Index Foods Can Decrease Systolic and Diastolic Blood Pressure in the Short Term</article-title>
<source>Int. J. Hypertens.</source>
<year>2015</year>
<volume>2015</volume>
<pub-id pub-id-type="doi">10.1155/2015/801268</pub-id>
<pub-id pub-id-type="pmid">26509082</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-08-00802-f001" position="float"><label>Figure 1</label><caption><p>Flow diagram of the study protocol with recruitment and randomization process. During low-physical activity with GI interventions, habitual high physical activity (&#x0003e;10,000 steps/day) was restricted to &#x0003c;3000 steps/day; CGM: continuous glucose monitoring; GI: glycemic index; high-GI (HGI): beverages sweetened with a mixture of maltodextrin (75%) and sucrose (25%); low-GI (LGI): beverages sweetened with isomaltulose; meal test: 37 g isomaltulose vs. 28 g maltodextrin + 9 g sucrose; OGTT: oral glucose tolerance test; PWA: pulse wave analysis.</p></caption><graphic xlink:href="nutrients-08-00802-g001"/></fig><fig id="nutrients-08-00802-f002" position="float"><label>Figure 2</label><caption><p>Comparison of postprandial Glucagon-like-peptide 1 (GLP-1) (<bold>A</bold>,<bold>B</bold>) levels and augmentation index (<bold>C</bold>,<bold>D</bold>) after intake of low glycemic index (<inline-graphic xlink:href="nutrients-08-00802-i001.jpg"/>) vs. high glycemic index (<inline-graphic xlink:href="nutrients-08-00802-i002.jpg"/>) SSB at the end of one week of low physical activity. AIx, augmentation index; GLP1, glucagon-like peptide-1; SSB: sugar-sweetened beverages; tAUC, total area under the curve; upper panel: mean &#x000b1; SEM, lower panel: mean &#x000b1; SD; differences between tAUC for low-GI and high-GI SSB were tested using paired <italic>t</italic>-test, * <italic>p</italic> &#x0003c; 0.05; ** <italic>p</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="nutrients-08-00802-g002"/></fig><fig id="nutrients-08-00802-f003" position="float"><label>Figure 3</label><caption><p>Daytime glycemia (iAUC<sub>GLC</sub>, <bold>A</bold>) and glucose variability (MAGE, <bold>B</bold>) during active and inactive phases with low-GI and high-GI SSB intervention. iAUC: incremental area under the curve; MAGE: mean amplitude of glycemic excursions; low-GI (LGI): beverages sweetened with isomaltulose; high-GI (HGI): beverages sweetened with a mixture of maltodextrin (75%) and sucrose (25%); mean &#x000b1; SD; two-way ANOVA with Bonferroni adjustment and paired <italic>t</italic>-test, * <italic>p</italic> &#x0003c; 0.05; ** <italic>p</italic> &#x0003c; 0.01, *** <italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="nutrients-08-00802-g003"/></fig><table-wrap id="nutrients-08-00802-t001" position="float"><object-id pub-id-type="pii">nutrients-08-00802-t001_Table 1</object-id><label>Table 1</label><caption><p>Basal characteristics and low physical activity-induced changes of body weight, fat mass and cardiovascular risk factors stratified by low-GI vs. high-GI SSB intervention, <italic>n</italic> = 13.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + Low-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + High-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + Low-GI&#x02014;Activity 1 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + High-GI&#x02014;Activity 2 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Difference Between Changes Upon Low Physical Activity <sup>2</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">24 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">23.4 &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Weight </td><td align="center" valign="middle" rowspan="1" colspan="1">78.8 &#x000b1; 9.8</td><td align="center" valign="middle" rowspan="1" colspan="1">78.7 &#x000b1; 9.8</td><td align="center" valign="middle" rowspan="1" colspan="1">78.7 &#x000b1; 9.2</td><td align="center" valign="middle" rowspan="1" colspan="1">78.2 &#x000b1; 9.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.1 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.5 &#x000b1; 0.7 *</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">FM (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.8 &#x000b1; 6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">14.3 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">13.4 &#x000b1; 5.7</td><td align="center" valign="middle" rowspan="1" colspan="1">14.1 &#x000b1; 5.6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 &#x000b1; 0.8 *</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 &#x000b1; 0.7 **</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Steps per day</td><td align="center" valign="middle" rowspan="1" colspan="1">11,051 &#x000b1; 3064</td><td align="center" valign="middle" rowspan="1" colspan="1">2263 &#x000b1; 861</td><td align="center" valign="middle" rowspan="1" colspan="1">11,699 &#x000b1; 3748</td><td align="center" valign="middle" rowspan="1" colspan="1">2463 &#x000b1; 1008</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8788 &#x000b1; 3131 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9236 &#x000b1; 3940 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Lipid profile</bold></td><td colspan="7" align="center" valign="middle" rowspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">TG (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">63.2 &#x000b1; 22.1</td><td align="center" valign="middle" rowspan="1" colspan="1">94.7 &#x000b1; 28.1</td><td align="center" valign="middle" rowspan="1" colspan="1">65.3 &#x000b1; 17.2</td><td align="center" valign="middle" rowspan="1" colspan="1">115.3 &#x000b1; 52.6</td><td align="center" valign="middle" rowspan="1" colspan="1">31.5 &#x000b1; 36.4 *</td><td align="center" valign="middle" rowspan="1" colspan="1">50.0 &#x000b1; 53.1 **</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesterin (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">152 &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">157 &#x000b1; 23</td><td align="center" valign="middle" rowspan="1" colspan="1">156 &#x000b1; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">156 &#x000b1; 28</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5 &#x000b1; 16.9 </td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.2 &#x000b1; 13.1 </td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HDL (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">45.8 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">41.5 &#x000b1; 7.0</td><td align="center" valign="middle" rowspan="1" colspan="1">47.4 &#x000b1; 7.0</td><td align="center" valign="middle" rowspan="1" colspan="1">42.2 &#x000b1; 7.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.2 &#x000b1; 5.7 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 4.3 **</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LDL (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">93.9 &#x000b1; 17.4</td><td align="center" valign="middle" rowspan="1" colspan="1">100.6 &#x000b1; 15.5</td><td align="center" valign="middle" rowspan="1" colspan="1">97.6 &#x000b1; 16.7</td><td align="center" valign="middle" rowspan="1" colspan="1">99.4 &#x000b1; 21.8</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7 &#x000b1; 12.4 </td><td align="center" valign="middle" rowspan="1" colspan="1">1.8 &#x000b1; 10.4</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cholesterin/HDL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.4 &#x000b1; 0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8 &#x000b1; 0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3 &#x000b1; 0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8 &#x000b1; 0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5 &#x000b1; 0.4 **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4 &#x000b1; 0.5 **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.s.</td></tr></tbody></table><table-wrap-foot><fn><p>GI: glycemic index; low-GI: isomaltulose; high-GI: mixture of 75% maltodextrin and 25% sucrose; SSB: sugar-sweetened beverage; BMI: body mass index; FM: fat mass; n.s.: not significant; TG: triglycerides; HDL: high density lipoptrotein; LDL: low density lipoprotein; <sup>1</sup> difference between active and inactive period; <sup>2</sup> difference between changes upon low physical activity with low-GI and high-GI SSB (activity &#x000d7; GI); * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01, *** <italic>p</italic> &#x0003c; 0.001, two-way ANOVA with Bonferroni adjustment; paired <italic>t</italic>-test. </p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-08-00802-t002" position="float"><object-id pub-id-type="pii">nutrients-08-00802-t002_Table 2</object-id><label>Table 2</label><caption><p>Comparison of low physical activity-induced changes in fasting insulin, insulin sensitivity (IS), C-peptide excretion, daylong glycemia and glucose variability between low-GI and high-GI SSB intervention. <italic>n</italic> = 13.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + Low-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + High-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + Low-GI&#x02014;Activity 1 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + High-GI&#x02014;Activity 2 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Difference between Changes upon Low Physical Activity <sup>2</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fasting insulin (mU/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1 &#x000b1; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">6.0 &#x000b1; 2.6</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8 &#x000b1; 1.8</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7 &#x000b1; 4.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9 &#x000b1; 2.4 *</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9 &#x000b1; 3.6 **</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HOMA-IR</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 &#x000b1; 1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 &#x000b1;0.5 **</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.9 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Matsuda-ISI</td><td align="center" valign="middle" rowspan="1" colspan="1">14.5 &#x000b1; 5.9</td><td align="center" valign="middle" rowspan="1" colspan="1">9.4 &#x000b1; 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">17.4 &#x000b1; 8.0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.8 &#x000b1; 3.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 5.5 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.6 &#x000b1; 5.1 **</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24-h C-peptide excretion (&#x000b5;g/day)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.6 &#x000b1; 20.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.0 &#x000b1; 15.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.7 &#x000b1; 18.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.8 &#x000b1; 24.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4 &#x000b1; 15.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.1 &#x000b1; 22.5 **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.05</td></tr></tbody></table><table-wrap-foot><fn><p>GI: glycemic index; low-GI: isomaltulose; high-GI: mixture of 75% maltodextrin and 25% sucrose; SSB: sugar-sweetened beverage; HOMA-IR: homeostasis model assessment of insulin resistance; Matsuda-ISI: Matsuda insulin sensitivity index; <sup>1</sup> difference between active and inactive period; <sup>2</sup> difference between changes upon low physical activity with low-GI and high-GI SSB (activity &#x000d7; GI); * <italic>p</italic> &#x0003c; 0.05, ** <italic>p</italic> &#x0003c; 0.01, *** <italic>p</italic> &#x0003c; 0.001, two-way ANOVA with Bonferroni adjustment; paired <italic>t</italic>-test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="nutrients-08-00802-t003" position="float"><object-id pub-id-type="pii">nutrients-08-00802-t003_Table 3</object-id><label>Table 3</label><caption><p>Comparison of low physical activity-induced changes in blood pressure and parameters of arterial stiffness between low-GI and high-GI SSB intervention. <italic>n</italic> = 13.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + Low-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity 2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Low Physical Activity + High-GI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + Low-GI&#x02014;Activity 1 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02206; Low Physical Activity + High-GI&#x02014;Activity 2 <sup>1</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Difference between Changes upon Low Physical Activity <sup>2</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">sBP (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">126 &#x000b1; 8</td><td align="center" valign="middle" rowspan="1" colspan="1">124 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">124 &#x000b1; 8</td><td align="center" valign="middle" rowspan="1" colspan="1">125 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.8 &#x000b1; 6.9 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 5.5 </td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">dBP (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">66 &#x000b1; 5</td><td align="center" valign="middle" rowspan="1" colspan="1">65 &#x000b1; 4</td><td align="center" valign="middle" rowspan="1" colspan="1">65 &#x000b1; 5</td><td align="center" valign="middle" rowspan="1" colspan="1">64 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.0 &#x000b1; 3.8 </td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.4 &#x000b1; 6.3</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">cBP (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">119 &#x000b1; 8</td><td align="center" valign="middle" rowspan="1" colspan="1">117 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">116 &#x000b1; 7</td><td align="center" valign="middle" rowspan="1" colspan="1">117 &#x000b1; 6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.3 &#x000b1; 5.9 </td><td align="center" valign="middle" rowspan="1" colspan="1">0.6 &#x000b1; 4.8 </td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AIx (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 &#x000b1; 3</td><td align="center" valign="middle" rowspan="1" colspan="1">14 &#x000b1; 3</td><td align="center" valign="middle" rowspan="1" colspan="1">13 &#x000b1; 4</td><td align="center" valign="middle" rowspan="1" colspan="1">14 &#x000b1; 4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0 &#x000b1; 2.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 &#x000b1; 3.0</td><td align="center" valign="middle" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PWV (m/s)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.5 &#x000b1; 0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.5 &#x000b1; 0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.4 &#x000b1; 0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.6 &#x000b1; 0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.3 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2 &#x000b1; 0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.s.</td></tr></tbody></table><table-wrap-foot><fn><p>GI: glycemic index; low-GI: isomaltulose; high-GI: mixture of 75% maltodextrin and 25% sucrose; n.s.: not significant; SSB: sugar-sweetened beverage; sBP: systolic blood pressure (brachial); diastolic blood pressure (brachial); cBP: central blood pressure; Aix: augmentation index; PWV: pulse wave velocity (carotid-femoral); <sup>1</sup> difference between active and inactive period; <sup>2</sup> difference between changes upon low physical activity with low-GI and high-GI SSB (activity &#x000d7; GI); two-way ANOVA with Bonferroni adjustment; paired <italic>t</italic>-test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>